middle.news
How Tetratherix’s Tutelix Trial Success and $3.3M Grant Could Transform Cancer Care
8:42am on Monday 27th of October, 2025 AEDT
•
Healthcare
Read Story
How Tetratherix’s Tutelix Trial Success and $3.3M Grant Could Transform Cancer Care
8:42am on Monday 27th of October, 2025 AEDT
Key Points
Positive first-in-human Tutelix trial results with no adverse events
Stage 2 recruitment underway across multiple Australian sites
Bone regeneration animal studies progressing on FDA clearance timeline
Secured $3.3 million Australian Government Industry Growth Program grant
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Tetratherix (ASX:TTX)
OPEN ARTICLE